ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results
Go back to ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results| (NASDAQ: ABVC) | Delayed: 0.94 +0.07 (8.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.87 | 52 Week High | $25.00 | |||
| Open | $0.93 | 52 Week Low | $1.00 | |||
| Day High | $0.95 | P/E | N/A | |||
| Day Low | $0.89 | EPS | $0.00 | |||
| Volume | 117,020 | |||||

